Strengthening Collaborative Care Pathways for CAR T-Cell Therapy in the Southwest-CAR T Collaborative Care Webinar Deck

CAR T Collaborative Care Webinar Deck - Southwest (9/16/2026)

Pdf Summary

This ACCC webinar, “Strengthening Collaborative Care Pathways for CAR T-Cell Therapy in the Southwest,” focused on improving access, coordination, and shared management of CAR T patients across community oncology programs and CAR T centers.<br /><br />The program highlighted ACCC’s role in translating clinical evidence into practical care improvements and introduced faculty from UT Southwestern, Sarah Cannon, and Texas Oncology. Learning objectives included timely referral, understanding eligibility and consultation decision points, addressing regional care barriers, and creating collaborative approaches for monitoring and toxicity management.<br /><br />A key theme was access barriers, especially travel distance, difficulty reaching the CAR T center, and caregiver requirements. Survey data from 136 cancer care professionals across 37 states showed broad agreement that CAR T improves outcomes, but infrastructure changes are needed, including more outpatient CAR T delivery, more local programs, and remote monitoring.<br /><br />The presentation reviewed the CAR T care continuum: referral, evaluation, insurance approval, leukapheresis, manufacturing, bridging therapy, lymphodepletion, infusion, and return to the referring provider. It emphasized that earlier referral is better and that “brain-to-vein” time matters.<br /><br />Post-treatment care was a major focus. The webinar outlined acute, early recovery, and long-term toxicities, including CRS, ICANS, infections, cytopenias, hypogammaglobulinemia, and rare delayed neurologic or secondary malignancy risks. It also described community provider responsibilities such as CBC monitoring, infection prevention, IVIG use, neurologic screening, and re-vaccination schedules.<br /><br />Continuous remote monitoring and telehealth were presented as tools to detect toxicity earlier, reduce inpatient days, and support safe outpatient or early-discharge pathways.<br /><br />A case discussion illustrated successful bidirectional care coordination for a patient with relapsed DLBCL treated with bridging chemotherapy, outpatient CAR T, close monitoring for CRS/ICANS, and structured handoff back to community oncology. The patient achieved durable remission.<br /><br />The webinar concluded by directing attendees to ACCC and Lymphoma Research Foundation resources for care continuity, shared care, social drivers of health, and patient support.

Keywords

CAR T-cell therapy

ACCC webinar

collaborative care pathways

community oncology

toxicity management

remote monitoring

telehealth

bridging therapy

DLBCL

care coordination